recent
mani
epidemiolog
studi
report
continu
circul
infect
enteroviru
viru
associ
sever
diseas
includ
acut
respiratori
distress
syndrom
ard
central
nervou
system
cn
clinic
sign
identifi
virul
factor
contribut
manifest
focu
mani
recent
studi
first
identifi
california
howev
evd
remain
poorli
character
speci
famili
picornavirida
notabl
mechan
lead
increas
pathogenesi
particularli
tropism
infect
human
upper
lower
respiratori
tract
remain
discov
clinic
data
shown
patholog
patient
lower
respiratori
tract
lrt
mainli
featur
seriou
respiratori
diseas
children
acut
flaccid
myeliti
studi
shown
import
pathway
infect
respiratori
tract
bind
sialic
acid
membran
shed
viru
upper
respiratori
tract
earli
immun
respons
patient
cytokin
secret
excret
well
document
translat
medicin
research
cotton
rat
model
studi
infect
transfer
help
character
behavior
viru
well
physiolog
respons
howev
use
cotton
ratadapt
strain
direct
intranas
intraperiton
inocul
mimic
natur
rout
infect
human
well
document
sialic
acid
surfac
respiratori
tract
mediat
influenza
viral
receptor
bind
protein
attach
believ
import
determin
tissu
tropism
viru
instanc
hemagglutinin
ha
human
influenza
virus
bind
prefer
sialic
acid
sa
domin
upper
respiratori
tract
urt
supposedli
indic
patholog
characterist
upper
respiratori
tract
anim
model
domest
ferret
mustela
putoriu
furo
convent
model
studi
pathogenesi
viral
respiratori
infect
includ
influenza
sever
acut
respiratori
syndrom
sar
coronaviru
need
viru
adapt
advantag
ferret
exhibit
similar
distribut
sialic
acid
respiratori
tract
human
due
respiratoryinfect
characterist
human
infect
effici
viru
ferret
could
key
anim
model
conduct
studi
infect
mechan
immun
respons
via
respiratori
tract
studi
focus
determin
whether
ferret
potenti
serv
small
anim
model
nose
aerosol
spray
use
induc
infect
ferret
model
serial
nasal
throat
fece
sampl
collect
ferret
infect
patholog
chang
express
level
inflammatori
cytokineschemokin
urt
lrt
ferret
correl
viral
shed
result
could
use
support
data
evalu
manifest
collect
data
provid
rational
assess
util
ferret
model
infect
anim
experi
studi
compli
replac
refin
reduct
principl
studi
also
accord
anim
research
report
vivo
experi
arriv
guidelin
anim
procedur
approv
institut
anim
care
use
committe
iacuc
institut
medic
biolog
chines
academi
medic
scienc
ferret
experi
conduct
total
male
ferret
weight
g
use
studi
serum
sampl
ferret
test
neutral
assay
ensur
seroneg
experi
fifteen
ferret
infect
cell
cultur
infecti
dose
via
nostril
dropwis
three
ferret
includ
immun
evalu
three
ferret
use
mock
control
inocul
ml
phosphatebuff
salin
pb
ferret
hous
higheffici
particul
airfilt
individu
isol
unit
anim
biosafeti
level
facil
compli
requir
ferret
hous
environ
comfort
describ
guid
laboratori
anim
care
issu
institut
medic
biolog
anim
visual
inspect
daili
bodi
weight
temperatur
measur
daili
two
week
postinfect
onset
durat
visibl
chang
abnorm
respir
excret
record
well
observ
sneez
nasal
discharg
blood
sampl
collect
viral
infect
anim
fece
nasal
wash
throat
swab
collect
day
challeng
frozen
analysi
infect
day
ferret
euthan
intramuscular
inject
ketamin
mgkg
organ
tissu
harvest
histopatholog
viral
distribut
analysi
last
sacrific
three
ferret
follow
day
determin
neutral
antibodi
titer
fermon
strain
use
studi
preserv
institut
medic
biolog
seed
stock
titer
unitsml
propag
vero
cell
atcc
seed
stock
dilut
appoint
titer
use
well
neutral
antibodi
assay
total
rna
extract
fresh
tissu
fece
bronchoalveolar
lavag
fluid
balf
blood
experiment
anim
use
trnzola
reagent
mini
kit
tiangen
biotech
co
ltd
beij
china
accord
manufactur
instruct
total
rna
elut
final
volum
quantif
singletub
realtim
taqman
rtpcr
assay
perform
use
taqman
onestep
rtpcr
master
mix
realtim
pcr
detect
system
biorad
laboratori
hercul
ca
usa
experi
carri
ad
primer
nm
famtamra
probe
nm
takara
biotechnolog
co
ltd
dalian
china
rna
taqman
pcr
mater
mix
total
reaction
volum
follow
sequenc
includ
primer
probe
forward
primer
revers
primer
probe
follow
reaction
condit
appli
pcr
experi
min
follow
cycl
standard
refer
curv
establish
measur
seriallydilut
concentr
rna
standard
gener
vitro
transcript
dna
gene
fragment
contain
gene
region
tissu
sampl
obtain
infect
ferret
fix
formalin
pb
embed
paraffin
paraffinembed
section
stain
hematoxylin
eosin
h
e
immunohistochem
detect
antigen
slide
paraffinembed
section
detect
monoclon
antibodi
genetex
inc
irvin
ca
usa
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antibodi
cell
signal
techonolog
shanghai
cstu
subsidiari
china
peroxidas
activ
detect
enhanc
hrpdab
chromogen
substrat
kit
tiangen
biotech
co
ltd
beij
china
lung
section
block
two
hour
normal
goat
serum
reduc
nonspecif
antibodi
bind
lung
incub
antibodi
genetex
inc
irvin
ca
usa
biotinyl
maa
sna
vector
laboratori
inc
ca
usa
overnight
section
rins
extens
trisbuff
salin
cell
nuclei
strain
dapi
beyotim
biotech
co
ltd
shanghai
china
primari
antibodi
detect
use
fluorescein
avidin
dc
vector
laboratori
inc
burlingam
ca
usa
texasredconjug
goat
antirabbit
igg
antibodi
molecular
probe
carlsbad
ca
usa
stain
slide
analyz
leica
tc
confoc
microscop
leica
microsystem
wetzlar
germani
studi
nonhuman
primat
cytokin
magnet
bead
panel
kit
millipor
corpor
billerica
usa
attempt
simultan
quantif
infect
ferret
serum
follow
kind
cytokin
gcsf
gmcsf
tgfa
tnfa
vegf
brief
aliquot
standard
control
sampl
dilut
diluent
follow
incub
antibodycoupl
bead
thoroughli
wash
detect
antibodi
ad
coincub
test
final
plate
run
bioplex
biorad
laboratori
inc
fiveparamet
logist
method
use
calcul
analyt
concentr
sampl
rna
isol
perform
ferret
lung
tissu
sampl
trnzola
reagent
kit
tiangen
biotech
co
ltd
beij
china
accord
manufactur
protocol
cytokin
express
level
normal
betaactin
report
fold
chang
compar
mockinfect
anim
primer
sequenc
publish
elsewher
primer
sequenc
remain
gene
follow
forward
revers
forward
revers
forward
revers
forward
revers
quantit
realtim
pcr
qrtpcr
perform
use
touchtm
realtim
pcr
detect
system
biorad
laboratori
one
step
sybr
primescripttm
rtpcr
kit
takara
biotechnolog
co
ltd
reaction
consist
cycl
min
follow
cycl
brief
ferret
serum
heatinactiv
min
dilut
minimum
essenti
medium
contain
fetal
bovin
serum
fb
gibco
lifetechbolog
shanghai
china
cool
medium
room
temperatur
dilut
serum
transfer
triplic
first
row
one
plate
dilut
twofold
one
hundr
combin
dilut
sera
white
opaquebottom
plate
incub
h
ad
vero
cellswel
incub
sampl
six
day
reciproc
measur
highest
serum
dilut
inhibit
viral
cytopath
effect
defin
neutral
antibodi
na
titer
rel
neutral
titer
estim
method
express
form
eg
titer
graphpad
prism
version
la
jolla
ca
usa
use
graph
data
perform
statist
analys
compar
blood
cell
count
cytokin
express
level
group
u
test
use
mean
sem
standard
error
mean
graph
p
consid
statist
signific
gener
patient
infect
viru
appear
variou
diseas
sever
rang
mild
respiratori
ill
coldlik
clinic
sign
sever
lower
respiratori
tract
infect
lrti
includ
pneumonia
wheez
bronchiol
studi
clinic
sign
respiratori
ill
includ
cough
nasal
discharg
figur
dri
nose
figur
present
infect
anim
signific
increas
bodi
temperatur
figur
observ
ferret
viru
infect
phenomenon
accord
clinic
report
patient
infect
character
lowgrad
absent
fever
although
increas
ferret
bodi
weight
figur
period
experiment
observ
uninfect
ferret
gain
weight
infect
ferret
mean
vs
day
postinfect
indic
overal
health
mock
ferret
better
addit
earli
infect
day
postinfect
ferret
infect
slightli
increas
neutrophil
mean
monocyt
mean
compar
three
day
postinfect
ferret
chang
number
lymphocyt
eosinophil
figur
similar
enterovirus
abil
infect
lymphocyt
addit
sever
epidemiolog
studi
demonstr
associ
sever
lower
respiratori
tract
infect
central
nervou
system
cn
pathogen
includ
acut
focal
limb
weak
paralysi
acut
cranial
nerv
dysfunct
research
partial
gene
nt
detect
use
rtpcr
analysi
sequencespecif
primer
probe
fece
nasal
wash
throat
swab
blood
lung
balf
trachea
cn
sampl
collect
differ
time
postinfect
ferret
viru
detect
fece
nasal
wash
third
day
postinfect
peak
level
copi
per
mg
sampl
figur
reach
fifth
day
copi
per
ml
nasal
wash
figur
detect
ninth
day
viru
detect
throat
swab
figur
viremia
infect
viral
load
blood
sampl
less
copiesml
figur
sever
studi
indic
enteroviru
invas
lead
transient
minor
viremia
deliv
viru
lymphoid
tissu
studi
viru
replic
axillari
lymph
node
detect
five
seven
day
postinfect
level
copi
per
mg
tissu
figur
measur
profil
viru
replic
lower
respiratori
system
viru
detect
lung
trachea
balf
infecti
virus
detect
three
seven
day
postinfect
peak
level
copi
per
mg
lung
tissu
fifth
day
postinfect
figur
howev
viral
load
balf
trachea
less
copiesml
figur
b
detect
fermon
strain
neg
cn
includ
brain
midbrain
cerebellum
medulla
oblongata
figur
although
clinic
result
report
possibl
associ
neurolog
diseas
observ
central
nervou
system
symptom
ferret
accord
schiebl
experiment
result
suck
mice
inocul
four
strain
cn
impair
observ
mice
infect
rhyne
fermon
franklin
robison
strain
two
clinic
case
report
diffus
patchi
alveolar
infiltr
present
lung
tissu
patient
accord
comput
tomographi
angiogram
chest
studi
tissu
sampl
trachea
lung
histopatholog
examin
order
observ
patholog
chang
respiratori
apparatu
ferret
infect
inflamm
diffus
alveolar
hemorrhag
found
lung
viral
load
level
high
ferret
three
seven
day
postinfect
figur
patholog
chang
trachea
figur
find
suggest
ferret
infect
might
remark
pathogenesi
lower
respiratori
tract
three
seven
day
postinfect
figur
time
immunolabel
antigen
observ
lung
cell
around
pulmonari
alveolu
cell
antigen
undetect
trachea
figur
togeth
viru
detect
histopatholog
analys
lung
tissu
like
demonstr
pulmonari
manifest
three
seven
day
postinfect
sialic
acid
sa
report
receptor
shown
stronger
affin
sa
sa
compar
distribut
sa
sa
cell
lung
viralinfect
anim
lung
sampl
stain
viru
protein
monoclon
antibodi
detect
texasredconjug
secondari
antibodi
figur
biotinyl
lectin
sna
maa
use
detect
sa
sa
respect
bound
lectin
distinguish
avidin
dc
label
fitc
figur
figur
ferret
found
sa
dominantli
express
lung
tissu
figur
sa
figur
howev
three
day
postinfect
seven
day
postinfect
overlaid
imag
two
color
green
red
exhibit
intens
coloc
sa
lung
cell
figur
remark
sa
observ
posit
lung
cell
accord
coloc
imag
figur
result
indic
infect
may
prefer
sa
sa
ferret
lower
respiratori
tract
figur
determin
possibl
patholog
progress
lrt
ferret
due
acut
lung
injuri
inflammatori
immun
respons
intend
evalu
inflammatori
cytokin
level
lung
earli
late
stage
infect
despit
promin
use
ferret
medic
research
immun
system
ferret
remain
poorli
character
insuffici
elisa
reagent
detect
cytokin
ferret
attempt
use
bioplex
suspens
array
system
evalu
serum
cytokin
level
numer
studi
report
mani
anim
speci
antibodi
specif
cytokin
use
detect
ferret
cytokin
therefor
studi
nonhuman
primat
cytokin
assay
use
crosstest
cytokin
chemokin
ferret
follow
protocol
user
manual
figur
verif
test
level
gene
express
also
measur
qrtpcr
result
indic
differenti
express
inflammatori
cytokineschemokin
lrt
show
high
express
level
figur
b
serum
figur
correl
peak
level
viral
shed
patholog
chang
lung
data
suggest
infect
increas
releas
inflammatori
cytokin
infect
ferret
lung
earli
infect
lung
patholog
continu
exacerb
progress
infect
caus
lung
edema
well
lung
injuri
middl
late
stage
infect
detect
abil
viral
infect
elicit
antibodi
respons
three
ferret
follow
day
inocul
immunolog
analysi
anim
show
typic
antibodi
respons
viralinduc
characterist
neutral
antibodi
gmt
exhibit
slight
slow
increas
level
week
inocul
figur
respect
report
patel
et
al
cotton
rat
model
fermon
infect
result
detect
neutral
antibodi
na
respons
find
studi
demonstr
fermon
strain
infect
may
induc
faint
immunolog
respons
form
neutral
antibodi
titer
ferret
determin
vivo
effect
viral
replic
pathogenesi
mice
rat
cotton
model
use
studi
infect
studi
cotton
rat
infect
nasal
fermon
strain
demonstr
rel
weak
infect
replic
profil
nonobvi
sign
patholog
chang
howev
abil
systemat
evalu
infect
progress
small
rodent
limit
model
yield
suffici
pathogen
patholog
evid
infect
analysi
therefor
implement
effect
ferret
model
repres
obligatori
step
preclin
evalu
respiratori
pathogen
infect
similar
distribut
profil
human
respiratori
tract
sa
ferret
domin
epithelia
urt
rel
increas
sa
lrt
along
continu
presenc
sa
ferret
larg
use
studi
respiratori
infect
influenza
respiratori
syncyti
viru
sar
viru
infect
pathway
report
respiratori
tract
indic
would
easier
induc
respiratori
infect
ferret
model
would
display
symptom
similar
human
studi
use
ferret
model
assess
clinic
symptom
viral
replic
shed
pathogen
express
inflammatori
cytokin
respiratori
tract
ferret
infect
viru
model
util
commonlyemploy
intranas
challeng
rout
ferret
assess
natur
mucos
rout
infect
result
found
clear
profil
viral
replic
rate
ferret
compar
result
cotton
rat
describ
patel
notabl
despit
direct
access
nose
upon
infect
observ
less
viral
shed
nasal
discharg
compar
fecal
matter
instead
impress
viral
burden
note
lung
similar
experiment
result
cotton
rat
infect
measur
directli
viral
titrat
studi
result
qrtpcr
viral
genom
immunohistochem
analysi
viral
antigen
support
viru
replic
infect
ferret
moreov
sinc
usual
target
respiratori
tract
infect
induc
sever
pneumonia
among
children
asthma
histori
wheez
also
focus
analyz
pathogenesi
urt
lrt
tissu
result
clearli
show
inflamm
diffus
alveolar
hemorrhag
occur
lung
ferret
three
seven
day
postinfect
suggest
ferret
infect
might
remark
pathogenesi
lower
respiratori
tract
despit
initi
common
coldlik
symptom
eg
runni
nose
sore
throat
cough
upper
respiratori
tract
seriou
pneumonialik
symptom
relat
lower
respiratori
tract
may
occur
case
thu
attach
invad
lrt
could
contribut
outcom
furthermor
investig
relationship
lectin
receptor
surfac
lower
respiratori
tract
cell
invas
find
sa
stain
appar
viral
infect
less
signal
appear
sa
indic
specif
recogn
sa
cell
tropism
ferret
lower
respiratori
tract
induc
lrt
infect
pathogen
chang
case
ferret
propos
good
smallanim
model
lower
respiratori
manifest
inflammatori
immun
respons
report
relat
acut
lung
injuri
viral
infect
assess
inflammatori
cytokin
chemokin
level
patholog
chang
lrt
serum
lung
earli
stage
infect
increas
express
inflammatori
cytokineschemokin
includ
correl
patholog
chang
lung
may
play
key
role
caus
lung
edema
well
lung
injuri
middl
late
stage
infect
taken
togeth
data
impli
ferret
model
potenti
use
character
key
event
pathogenesi
even
fermon
strain
lower
antigen
model
may
use
evalu
newlyisol
strain
potenti
candid
medic
intervent
includ
vaccin
studi
need
fulli
character
transmiss
infect
ferret
expand
predict
efficaci
model
intens
studi
